we’ll eventually need more money in 2-3 years time, is ok to run stealth till then (saves money too - no need for pitches/presentations - just focus on discovery) maximize the seeds we can plant now and ramp up the watering (raises) later when they are ready to bear fruit (enter clinic). Hopefully by then they have a scaleable factory like approach based on the RP-11 playbook to bring the rest to market (the data to date is brilliant and the videos/collateral with clinicians/patients and is good too - I can see them expanding to respective advocacy groups globally)
In 3 years time, we might be getting dividends from RP11 if all goes well. I have faith in their pipeline, happy to re-invest at that time if they have a DRP facility
Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 25000 | 1 |
View Market Depth
| Last trade - 09.11am 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |
Day chart unavailable